424B5ENTACIK 0001177648
ENANTA PHARMACEUTICALS INC
Prospectus supplement (424B5) filed .
Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.
Filing facts
- Accession number
- 0001193125-25-226794
- Filer
- ENANTA PHARMACEUTICALS INC
- Ticker
- ENTA
- CIK
- 0001177648
- Form type
- 424B5
- Form description
- Prospectus supplement
- Filed at
- October 1, 2025
- Filing size
- 569.6 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from ENANTA PHARMACEUTICALS INC
See all 43 filings from ENANTA PHARMACEUTICALS INC →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1177648/000119312525226794/0001193125-25-226794-index.htm ↗Filer's full EDGAR submission history
EDGAR · ENANTA PHARMACEUTICALS INC (0001177648) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001193125-25-226794.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.